What to expect when you take Renagel and have Pain relief by acupuncture?

Do you take Renagel and have Pain relief by acupuncture? Find out below what new side effects and undetected conditions you may have in 1 to 5 years. This forecast is created after we perform predictive analysis on healthcare big data, including data collected from FDA. It will be updated regularly.

To personalized this forecast to you, click here.




Female

Females aged 1:

Within 1 year:

  • n/a
back to top

Within 2 years:

  • n/a
back to top

Within 3 years:

  • n/a
back to top

Within 4 years:

  • n/a
back to top

Within 5 years:

  • n/a
back to top

Females aged 18:

Within 1 year:

  • n/a
back to top

Within 2 years:

  • n/a
back to top

Within 3 years:

  • n/a
back to top

Within 4 years:

Most common symptoms:

  • n/a

Fastest developing symptoms:

  1. Anaemia (45%)
  2. Hypotension (36%)
  3. Gastritis Erosive (27%)
  4. Deep Venous Thrombosis (27%)
  5. Gastrointestinal Haemorrhage (27%)
  6. Device Related Infection (27%)
  7. Bleeding Disorders (27%)
  8. Headache (27%)
  9. Dieulafoy's Vascular Malformation (27%)
  10. Nausea (27%)

Other co-existing conditions:

  1. Hyperphosphataemia (18%)
  2. Haemolytic Uraemic Syndrome (18%)
  3. Vitamin Supplementation (9%)
  4. Renal Failure Chronic (9%)
  5. Osteoporosis (9%)
  6. Oedema Peripheral (9%)
  7. Nephrogenic Anaemia (9%)
  8. Hyperparathyroidism (9%)
  9. Hyperglycemia (9%)
  10. High Blood Pressure (9%)
back to top

Within 5 years:

Most common symptoms:

  1. Pneumonia (5%)

Fastest developing symptoms:

  1. Anti-Erythropoietin Antibody Positive (32%)
  2. Haemorrhoids (26%)
  3. Blood Pressure Diastolic Decreased (26%)
  4. Dysfunctional Uterine Bleeding (dub) (26%)
  5. Drug Ineffective (26%)
  6. Nosebleed (26%)
  7. Ichthyosis (26%)
  8. Lymph Follicular Hypertrophy (26%)
  9. Aplasia Pure Red Cell (26%)
  10. Gastritis (26%)

Other co-existing conditions:

  1. Dialysis (26%)
  2. Hepatitis C (11%)
  3. Nuclear Magnetic Resonance Imaging Brain (5%)
  4. Lower Extremity Venography (5%)
  5. Hyperphosphataemia (5%)
  6. Hyperparathyroidism Secondary (5%)
  7. Haemolytic Uraemic Syndrome (5%)
  8. Arteriogram (5%)
back to top

Females aged 45:

Within 1 year:

Most common symptoms:

  1. Nephrogenic Systemic Fibrosis (28%)
  2. Oedema Peripheral (26%)
  3. Skin Tightness (16%)
  4. Skin Hypertrophy (16%)
  5. Skin Discoloration (16%)
  6. Skin Induration (14%)
  7. Hypotension (9%)
  8. Hypocalcaemia (9%)
  9. Peritonitis (7%)

Fastest developing symptoms:

  1. Weakness (23%)
  2. Paraesthesia (19%)
  3. Diarrhea (16%)
  4. Joint Pain (16%)
  5. Pain In Extremity (16%)
  6. Dizziness (14%)
  7. Nausea (14%)
  8. Nausea And Vomiting (14%)
  9. Dry Skin (14%)
  10. Oedema (14%)

Other co-existing conditions:

  1. Hyperphosphataemia (19%)
  2. Arteriogram (19%)
  3. Nuclear Magnetic Resonance Imaging Brain (16%)
  4. Lower Extremity Venography (14%)
  5. Nuclear Magnetic Resonance Imaging Abdominal (12%)
  6. Hyperparathyroidism Secondary (9%)
  7. Blood Phosphorus Increased (7%)
back to top

Within 2 years:

Most common symptoms:

  1. Nephrogenic Systemic Fibrosis (30%)
  2. Skin Induration (22%)
  3. Skin Tightness (18%)
  4. Oedema Peripheral (18%)
  5. Rashes (15%)
  6. Skin Hypertrophy (9%)
  7. Skin Discoloration (9%)
  8. Depression (9%)

Fastest developing symptoms:

  1. Gait Disturbance (16%)
  2. Nausea (16%)
  3. Stress And Anxiety (15%)
  4. Emotional Distress (15%)
  5. Hypoaesthesia (13%)
  6. Pain In Extremity (13%)
  7. Joint Contracture (12%)
  8. Vaginal Haemorrhage (12%)
  9. Dyspnea (12%)
  10. Abdominal Pain (12%)

Other co-existing conditions:

  1. Arteriogram (19%)
  2. Nuclear Magnetic Resonance Imaging Brain (10%)
  3. Nuclear Magnetic Resonance Imaging Abdominal (9%)
  4. Dialysis (9%)
  5. Cardiac Disorder (9%)
  6. Nausea (7%)
  7. Hypotension (7%)
  8. Haemorrhage Intracranial (7%)
  9. Renal Failure Chronic (6%)
  10. Hyperphosphataemia (6%)
back to top

Within 3 years:

Most common symptoms:

  1. Nephrogenic Systemic Fibrosis (14%)
  2. Hypotension (14%)
  3. Rashes (6%)

Fastest developing symptoms:

  1. Itching (14%)
  2. General Physical Health Deterioration (12%)
  3. Stress And Anxiety (10%)
  4. Scar (10%)
  5. Peritonitis Bacterial (8%)
  6. Anaemia (6%)
  7. Dizziness (6%)
  8. Dyspnea (6%)
  9. Gait Disturbance (6%)
  10. Gastric Ulcer Haemorrhage (6%)

Other co-existing conditions:

  1. Hyperphosphataemia (20%)
  2. Dialysis (20%)
  3. High Blood Pressure (10%)
  4. Nuclear Magnetic Resonance Imaging Abdominal (8%)
  5. Insomnia (8%)
  6. Systemic Lupus Erythematosus (6%)
  7. Primary Pulmonary Hypertension (6%)
back to top

Within 4 years:

Most common symptoms:

  1. Rashes (27%)
  2. Nephrogenic Systemic Fibrosis (25%)
  3. Skin Induration (23%)
  4. Skin Hypertrophy (23%)
  5. Skin Tightness (22%)
  6. Oedema Peripheral (18%)
  7. Hypotension (13%)
  8. Skin Discoloration (10%)

Fastest developing symptoms:

  1. Weakness (25%)
  2. Scar (23%)
  3. Injury (23%)
  4. Skin Hyperpigmentation (22%)
  5. Joint Range Of Motion Decreased (22%)
  6. General Physical Health Deterioration (22%)
  7. Skin Disorder (22%)
  8. Hypoaesthesia (18%)
  9. Itching (18%)
  10. Stress And Anxiety (17%)

Other co-existing conditions:

  1. Hyperphosphataemia (27%)
  2. Nuclear Magnetic Resonance Imaging Abdominal (13%)
  3. Lower Extremity Venography (7%)
  4. Hyperparathyroidism Secondary (7%)
back to top

Within 5 years:

Most common symptoms:

  1. Hypotension (13%)
  2. Fever (10%)
  3. Rashes (6%)
  4. Nephrogenic Systemic Fibrosis (6%)
  5. Skin Induration (5%)
  6. Skin Discoloration (5%)

Fastest developing symptoms:

  1. Nausea (14%)
  2. Nausea And Vomiting (13%)
  3. Dizziness (11%)
  4. Pain In Extremity (10%)
  5. Fainting (9%)
  6. Renal Failure Chronic (8%)
  7. Cardiac Failure Congestive (6%)
  8. Dyspnea (6%)
  9. Weakness (5%)
  10. Emotional Distress (5%)

Other co-existing conditions:

  1. Hyperphosphataemia (19%)
  2. Hyperparathyroidism Secondary (18%)
  3. Dialysis (11%)
  4. Renal Failure Chronic (9%)
  5. Hyperparathyroidism (6%)
back to top

Females aged 65:

Within 1 year:

Most common symptoms:

  1. Nephrogenic Systemic Fibrosis (16%)
  2. Fatigue (16%)
  3. Weakness (15%)
  4. Hypotension (15%)
  5. Hypoaesthesia (15%)
  6. Nausea (11%)
  7. Haemoglobin Decreased (8%)
  8. Thrombocytopenia (6%)
  9. Malnutrition (6%)
  10. Hyperphosphataemia (6%)

Fastest developing symptoms:

  1. Itching (16%)
  2. Skin Hypertrophy (16%)
  3. Peau D'orange (15%)
  4. Skin Induration (15%)
  5. Paraesthesia (15%)
  6. Skin Disorder (11%)
  7. Skin Hyperpigmentation (10%)
  8. Musculoskeletal Pain (8%)
  9. Musculoskeletal Stiffness (8%)
  10. Joint Range Of Motion Decreased (8%)

Other co-existing conditions:

  1. Hyperphosphataemia (16%)
  2. Hyperparathyroidism Secondary (8%)
  3. Nuclear Magnetic Resonance Imaging Abdominal (6%)
  4. Diabetes (6%)
  5. Coronary Heart Disease (6%)
back to top

Within 2 years:

Most common symptoms:

  1. Nausea (17%)
  2. Fever (15%)
  3. Nausea And Vomiting (10%)
  4. Weakness (7%)
  5. Sepsis (7%)
  6. Oedema Peripheral (7%)
  7. Metabolic Acidosis (7%)
  8. Stress And Anxiety (6%)
  9. Hyperkalemia (6%)
  10. Dyspnea (6%)

Fastest developing symptoms:

  1. Constipation (13%)
  2. Fall (8%)
  3. Abdominal Distension (7%)
  4. Anaemia (7%)
  5. Anorexia (7%)
  6. Aortic Valve Replacement (6%)
  7. Coronary Artery Bypass (6%)
  8. Diabetic Ketoacidosis (6%)
  9. Emotional Distress (6%)
  10. Renal Impairment (6%)

Other co-existing conditions:

  1. Hyperphosphataemia (33%)
  2. Hyperparathyroidism Secondary (14%)
  3. High Blood Pressure (13%)
  4. Anaemia (10%)
  5. Nephrogenic Anaemia (7%)
  6. Gastroesophageal Reflux Disease (7%)
  7. Diarrhea (7%)
  8. Type 2 Diabetes (6%)
  9. Hypothyroidism (6%)
back to top

Within 3 years:

Most common symptoms:

  1. Weakness (35%)
  2. Stress And Anxiety (26%)
  3. Nausea And Vomiting (23%)
  4. Hypoaesthesia (22%)
  5. Nausea (21%)
  6. Back Pain (21%)
  7. Bone Disorder (20%)
  8. Joint Pain (20%)
  9. Tooth Disorder (20%)
  10. Pancytopenia (19%)

Fastest developing symptoms:

  1. Acute Kidney Failure (21%)
  2. Fall (21%)
  3. Intervertebral Disc Protrusion (21%)
  4. Limb Discomfort (21%)
  5. Joint Injury (20%)
  6. Osteolysis (20%)
  7. Back Disorder (20%)
  8. Impaired Healing (20%)
  9. Salivary Gland Disorder (20%)
  10. Radicular Pain (20%)

Other co-existing conditions:

  1. Hyperphosphataemia (29%)
  2. Multiple Myeloma (21%)
  3. Limb Discomfort (21%)
  4. Herpes Zoster (13%)
  5. Hyperparathyroidism Secondary (10%)
  6. Acute Kidney Failure (7%)
  7. High Blood Pressure (6%)
back to top

Within 4 years:

Most common symptoms:

  1. Weakness (15%)
  2. Nephrogenic Systemic Fibrosis (15%)
  3. Nausea And Vomiting (15%)
  4. Nausea (15%)
  5. Diarrhea (13%)
  6. Stress And Anxiety (10%)
  7. Death (10%)
  8. Hypoaesthesia (10%)
  9. Hypotension (10%)
  10. Injury (8%)

Fastest developing symptoms:

  1. Rashes (17%)
  2. Mobility Decreased (13%)
  3. Skin Induration (13%)
  4. Skin Hypertrophy (13%)
  5. Scar (10%)
  6. Ocular Icterus (10%)
  7. Emotional Distress (10%)
  8. Dry Skin (10%)
  9. Deformity (10%)
  10. Acute Kidney Failure (10%)

Other co-existing conditions:

  1. Hyperphosphataemia (17%)
  2. Coronary Artery Bypass (6%)
back to top

Within 5 years:

Most common symptoms:

  1. Nausea And Vomiting (24%)
  2. Nausea (24%)
  3. Hypotension (22%)
  4. Dizziness (22%)
  5. Abdominal Pain (18%)
  6. Chest Pain (16%)
  7. Dyspnea (16%)
  8. Fainting (16%)
  9. Malaise (16%)
  10. Oedema Peripheral (14%)

Fastest developing symptoms:

  1. Unresponsive To Stimuli (18%)
  2. Rashes (18%)
  3. Hyperhidrosis (16%)
  4. Heart Palpitations (16%)
  5. Headache (16%)
  6. Dyskinesia (16%)
  7. Paleness (16%)
  8. Drug Ineffective (16%)
  9. Paraesthesia (16%)
  10. Pharyngeal Oedema (16%)

Other co-existing conditions:

  1. Hyperphosphataemia (22%)
  2. Dialysis (18%)
  3. Multiple Myeloma (8%)
  4. Arteriogram (8%)
  5. Primary Pulmonary Hypertension (6%)
  6. Preventive Health Care (6%)
back to top

Male

Males aged 1:

Within 1 year:

  • n/a
back to top

Within 2 years:

  • n/a
back to top

Within 3 years:

  • n/a
back to top

Within 4 years:

  • n/a
back to top

Within 5 years:

  • n/a
back to top

Males aged 18:

Within 1 year:

  • n/a
back to top

Within 2 years:

Most common symptoms:

  1. Dyspnea (13%)

Fastest developing symptoms:

  1. High Blood Pressure (20%)
  2. Blood Phosphorus Increased (13%)
  3. Nasal Congestion (13%)
  4. Nausea And Vomiting (13%)
  5. Nephrogenic Systemic Fibrosis (13%)
  6. Hypertensive Encephalopathy (13%)
  7. Swollen Tongue (13%)
  8. Eyelid Oedema (13%)
  9. Pharyngeal Oedema (13%)
  10. Blood Sodium Increased (13%)

Other co-existing conditions:

  1. High Blood Pressure (33%)
  2. Preventive Health Care (20%)
  3. Urinary Incontinence (13%)
  4. Dialysis (13%)
  5. Transplant (13%)
  6. Acute Lymphocytic Leukemia (all) (7%)
  7. Anaemia (7%)
  8. Arteriogram (7%)
  9. Blood Growth Hormone Increased (7%)
  10. Constipation (7%)
back to top

Within 3 years:

Most common symptoms:

  • n/a

Fastest developing symptoms:

  1. Arrhythmias (40%)
  2. Peritonitis (40%)
  3. Grand Mal Convulsion (30%)
  4. Drug Maladministration (20%)
  5. Body Temperature Increased (20%)
  6. Sepsis (10%)
  7. Anaemia (10%)
  8. Dehydration (10%)
  9. Diarrhea (10%)
  10. Fatigue (10%)

Other co-existing conditions:

  1. Hyperparathyroidism Secondary (10%)
  2. Hiv Infection (10%)
  3. Dialysis (10%)
back to top

Within 4 years:

Most common symptoms:

  1. Dyspnea (23%)
  2. Chest Pain (15%)

Fastest developing symptoms:

  1. Hyperparathyroidism Secondary (38%)
  2. Joint Pain (23%)
  3. Vascular Calcification (23%)
  4. High Blood Pressure (23%)
  5. Fall (23%)
  6. Back Pain (23%)
  7. Pulmonary Oedema (15%)
  8. Joint Lock (15%)
  9. Impaired Gastric Emptying (15%)
  10. Musculoskeletal Pain (15%)

Other co-existing conditions:

  1. Dialysis (38%)
  2. Hyperparathyroidism Secondary (38%)
  3. High Blood Pressure (23%)
  4. Hyperparathyroidism (15%)
  5. Joint Swelling (15%)
  6. Gastritis Erosive (15%)
  7. Blood Pressure Management (15%)
  8. Tumor (15%)
  9. Back Pain (15%)
  10. Kidney Transplant (15%)
back to top

Within 5 years:

Most common symptoms:

  • n/a

Fastest developing symptoms:

  1. Abasia (27%)
  2. Joint Range Of Motion Decreased (27%)
  3. Cachexia (27%)
  4. High Blood Pressure (27%)
  5. Ascites (27%)
  6. Hypoglycemia (27%)
  7. Tendon Disorder (27%)
  8. Joint Contracture (27%)
  9. Joint Pain (27%)
  10. Nephrogenic Systemic Fibrosis (27%)

Other co-existing conditions:

  1. Nuclear Magnetic Resonance Imaging Brain (27%)
  2. Lower Extremity Venography (27%)
  3. Arteriogram (27%)
  4. Acute Kidney Failure (27%)
  5. Acute Lymphocytic Leukemia (all) (18%)
  6. High Blood Pressure (9%)
back to top

Males aged 45:

Within 1 year:

Most common symptoms:

  1. Dyspnea (17%)
  2. Pain In Extremity (15%)
  3. Nausea (15%)
  4. Skin Exfoliation (13%)
  5. Nephrogenic Systemic Fibrosis (13%)
  6. Hypoaesthesia (13%)
  7. Skin Induration (10%)
  8. Rashes (10%)
  9. Oedema Peripheral (10%)
  10. Paraesthesia (8%)

Fastest developing symptoms:

  1. Abdominal Pain (18%)
  2. Hyperhidrosis (15%)
  3. Peritonitis (13%)
  4. Chest Pain (13%)
  5. Deformity (13%)
  6. Mobility Decreased (13%)
  7. Weakness (13%)
  8. Itching (13%)
  9. Skin Hypertrophy (13%)
  10. Joint Pain (12%)

Other co-existing conditions:

  1. Hyperphosphataemia (32%)
  2. Hyperparathyroidism Secondary (12%)
  3. Renal Failure Chronic (10%)
  4. Nuclear Magnetic Resonance Imaging Brain (10%)
  5. Dialysis (10%)
  6. High Blood Pressure (7%)
  7. Anaemia (7%)
back to top

Within 2 years:

Most common symptoms:

  1. Oedema Peripheral (11%)
  2. Dyspnea (11%)
  3. Nausea (10%)
  4. Dizziness (8%)
  5. Rashes (7%)
  6. Pain In Extremity (7%)
  7. Nephrogenic Systemic Fibrosis (7%)

Fastest developing symptoms:

  1. Nausea And Vomiting (13%)
  2. Weakness (10%)
  3. Fever (10%)
  4. Hyperkalemia (10%)
  5. Hypotension (10%)
  6. Thrombocytopenia (10%)
  7. Abdominal Pain (10%)
  8. Stress And Anxiety (8%)
  9. High Blood Pressure (8%)
  10. Chest Pain (8%)

Other co-existing conditions:

  1. Multiple Myeloma (10%)
  2. Hyperphosphataemia (10%)
  3. High Blood Pressure (8%)
  4. Anaemia (8%)
  5. Hyperparathyroidism Secondary (7%)
  6. Dialysis (7%)
  7. Diabetes (7%)
  8. Depression (7%)
  9. Constipation (7%)
back to top

Within 3 years:

Most common symptoms:

  1. Nephrogenic Systemic Fibrosis (30%)
  2. Skin Induration (11%)
  3. Oedema Peripheral (11%)
  4. Nausea (8%)

Fastest developing symptoms:

  1. Weakness (15%)
  2. Emotional Distress (11%)
  3. Joint Range Of Motion Decreased (11%)
  4. Joint Contracture (11%)
  5. Stress And Anxiety (9%)
  6. Skin Tightness (9%)
  7. Anhedonia (9%)
  8. Balance Disorder (8%)
  9. Diarrhea (8%)
  10. Extremity Contracture (8%)

Other co-existing conditions:

  1. Hyperphosphataemia (24%)
  2. Arteriogram (15%)
  3. Dialysis (8%)
  4. High Blood Pressure (6%)
back to top

Within 4 years:

Most common symptoms:

  1. Oedema Peripheral (18%)
  2. Nausea (17%)
  3. Nephrogenic Systemic Fibrosis (16%)
  4. Dizziness (14%)
  5. Rashes (11%)
  6. Pain In Extremity (11%)
  7. Dyspnea (11%)
  8. Headache (9%)
  9. Oedema (8%)
  10. Back Pain (8%)

Fastest developing symptoms:

  1. Weakness (16%)
  2. Hypotension (14%)
  3. Fever (13%)
  4. Joint Pain (13%)
  5. Scar (13%)
  6. Diverticulitis (13%)
  7. General Physical Health Deterioration (13%)
  8. Hyperphosphataemia (12%)
  9. Renal Failure Chronic (12%)
  10. Neuropathy Peripheral (12%)

Other co-existing conditions:

  1. Hyperphosphataemia (21%)
  2. Nuclear Magnetic Resonance Imaging Brain (13%)
  3. Dialysis (12%)
  4. Anaemia (7%)
  5. Multiple Myeloma (5%)
  6. High Blood Pressure (5%)
  7. High Blood Cholesterol (5%)
  8. Hepatitis C (5%)
back to top

Within 5 years:

Most common symptoms:

  1. Nephrogenic Systemic Fibrosis (26%)
  2. Oedema Peripheral (13%)
  3. Nausea (13%)
  4. Skin Induration (11%)
  5. Skin Hyperpigmentation (10%)
  6. Dyspnea (9%)
  7. Skin Fibrosis (8%)
  8. Dizziness (7%)
  9. Headache (6%)

Fastest developing symptoms:

  1. Nausea And Vomiting (17%)
  2. Weakness (16%)
  3. Mobility Decreased (14%)
  4. Skin Hypertrophy (14%)
  5. Diarrhea (13%)
  6. Fibrosis (12%)
  7. General Physical Health Deterioration (12%)
  8. Joint Stiffness (12%)
  9. Joint Range Of Motion Decreased (12%)
  10. Musculoskeletal Stiffness (11%)

Other co-existing conditions:

  1. Hyperphosphataemia (20%)
  2. Arteriogram (13%)
  3. Acute Kidney Failure (9%)
  4. Nuclear Magnetic Resonance Imaging Brain (8%)
  5. Dialysis (6%)
  6. High Blood Pressure (6%)
  7. Diabetes (6%)
back to top

Males aged 65:

Within 1 year:

Most common symptoms:

  1. Stress And Anxiety (9%)
  2. Nephrogenic Systemic Fibrosis (9%)
  3. Weakness (8%)
  4. Anaemia (8%)
  5. Depression (7%)
  6. Respiratory Acidosis (6%)

Fastest developing symptoms:

  1. Insomnia (14%)
  2. Hallucinations (12%)
  3. Pulmonary Hypertension (11%)
  4. Photosensitivity Reaction (11%)
  5. Fall (9%)
  6. Sepsis (8%)
  7. Neurotoxicity (8%)
  8. Heart Attack (8%)
  9. Encephalopathy (7%)
  10. Cardiac Arrest (7%)

Other co-existing conditions:

  1. Hyperphosphataemia (21%)
  2. Herpes Zoster (10%)
  3. Dialysis (9%)
  4. Multiple Myeloma (8%)
  5. Hyperparathyroidism Secondary (8%)
  6. Preventive Health Care (7%)
  7. Renal Failure Chronic (6%)
  8. Kidney Transplant (6%)
  9. Arteriogram (6%)
back to top

Within 2 years:

Most common symptoms:

  1. Nephrogenic Systemic Fibrosis (27%)
  2. Oedema Peripheral (21%)
  3. Rashes (16%)
  4. Itching (16%)
  5. Scar (15%)
  6. Emotional Distress (14%)
  7. Musculoskeletal Stiffness (13%)
  8. Weakness (12%)
  9. Nausea (12%)
  10. Nausea And Vomiting (8%)

Fastest developing symptoms:

  1. Intestinal Obstruction (20%)
  2. General Physical Health Deterioration (16%)
  3. Skin Tightness (15%)
  4. Joint Range Of Motion Decreased (15%)
  5. Skin Hypertrophy (15%)
  6. Mobility Decreased (15%)
  7. Skin Induration (14%)
  8. Skin Ulcer (14%)
  9. Pain In Extremity (14%)
  10. Confusional State (13%)

Other co-existing conditions:

  1. Hyperphosphataemia (39%)
  2. Arteriogram (12%)
  3. High Blood Pressure (9%)
  4. Renal Failure Chronic (5%)
  5. Hyperparathyroidism Secondary (5%)
  6. Dialysis (5%)
  7. Constipation (5%)
back to top

Within 3 years:

Most common symptoms:

  1. Anaemia (12%)
  2. Weakness (9%)
  3. Hypotension (9%)
  4. Nephrogenic Systemic Fibrosis (6%)
  5. Joint Stiffness (6%)
  6. Peritonitis (5%)
  7. Musculoskeletal Stiffness (5%)
  8. Itching (5%)
  9. Dyspnea (5%)
  10. Cardio-Respiratory Arrest (5%)

Fastest developing symptoms:

  1. Fall (8%)
  2. Pneumonia (8%)
  3. Agranulocytosis (6%)
  4. Overdose (6%)
  5. Aplasia Pure Red Cell (6%)
  6. Fatigue (6%)
  7. Peritonitis Bacterial (6%)
  8. Oedema (6%)
  9. Altered State Of Consciousness (5%)
  10. Anastomotic Ulcer (5%)

Other co-existing conditions:

  1. Hyperphosphataemia (24%)
  2. Renal Failure Chronic (13%)
  3. High Blood Pressure (9%)
  4. Hyperparathyroidism Secondary (8%)
  5. Dialysis (8%)
  6. Preventive Health Care (6%)
  7. Nephrogenic Anaemia (6%)
  8. Gout (6%)
  9. Diabetes (6%)
  10. Nuclear Magnetic Resonance Imaging Brain (5%)
back to top

Within 4 years:

Most common symptoms:

  1. Dizziness (16%)
  2. Hypotension (8%)
  3. Nephrogenic Systemic Fibrosis (5%)
  4. Fever (5%)
  5. Diarrhea (5%)
  6. Constipation (5%)

Fastest developing symptoms:

  1. Fainting (9%)
  2. Atrial Fibrillation/flutter (9%)
  3. Cardiac Failure Congestive (9%)
  4. Confusional State (9%)
  5. Hallucination, Visual (9%)
  6. Gastrointestinal Haemorrhage (8%)
  7. Peripheral Arterial Occlusive Disease (8%)
  8. Cardiac Failure (7%)
  9. Encephalopathy (7%)
  10. Skin Ulcer (7%)

Other co-existing conditions:

  1. Hyperphosphataemia (36%)
  2. Hyperparathyroidism Secondary (13%)
  3. High Blood Pressure (12%)
  4. Herpes Zoster (11%)
  5. Dialysis (8%)
back to top

Within 5 years:

Most common symptoms:

  1. Weakness (12%)
  2. Itching (12%)
  3. Nausea (11%)
  4. Diarrhea (10%)
  5. Anaemia (10%)
  6. Nephrogenic Systemic Fibrosis (8%)
  7. Musculoskeletal Stiffness (8%)
  8. Hypotension (8%)
  9. Abdominal Pain (8%)
  10. Rashes (6%)

Fastest developing symptoms:

  1. Skin Hypertrophy (8%)
  2. Pain In Extremity (8%)
  3. Skin Tightness (6%)
  4. Rash Papular (6%)
  5. Joint Range Of Motion Decreased (6%)
  6. Fall (6%)
  7. Skin Induration (5%)
  8. Optic Ischaemic Neuropathy (5%)
  9. Lymphangitis (5%)
  10. Joint Pain (5%)

Other co-existing conditions:

  1. Hyperphosphataemia (26%)
  2. Hyperparathyroidism Secondary (12%)
  3. Dialysis (12%)
  4. High Blood Pressure (9%)
  5. Anaemia (9%)
  6. Arteriogram (5%)
back to top

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.